Trademark: 78931095
Word
INSTATAB
Status
Dead
Status Code
606
Status Date
Monday, April 25, 2011
Serial Number
78931095
Mark Type
4000
Filing Date
Monday, July 17, 2006
Published for Opposition
Tuesday, January 1, 2008
Abandoned Date
Monday, April 25, 2011

Trademark Owner History

Classifications
5 Pharmaceutical preparations and substances for the prevention, treatment and alleviation of stress; pharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes; pharmaceutical preparations and substances for controlling insulin levels; pharmaceutical preparations and substances for the prevention, treatment and alleviation of hypertension; pharmaceutical preparations and substances for the prevention, treatment and alleviation of angina; pharmaceutical preparations and substances for the cessation of smoking; pharmaceutical preparations and substances for the prevention and treatment of sexually transmitted diseases; pharmaceutical preparations and substances for the prevention and treatment of herpes; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the central nervous system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of depression; anti-depressants; pharmaceutical preparations and substances for the prevention, treatment and alleviation of sleep disorders; pharmaceutical preparations and substances for the prevention, treatment and alleviation of anxiety; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardio-vascular system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of acute myocardial infarctions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of symptomatic congestive heart failure; pharmaceutical preparations and substances for the prevention, treatment and alleviation of asymptomatic left ventricular dysfunction; pharmaceutical preparations and substances, namely, fibrinolytic or thrombolytic agents; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the respiratory system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the endocrine system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the immune system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the musculo-skeletal system, namely, bone diseases and bone degenerative conditions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain and inflammation, namely, pain relief medication and anti-inflammatories; pharmaceutical preparations and substances for the prevention, treatment and alleviation of migraines; pharmaceutical preparations and substances, namely, medicated skin care preparations for use in dermatology, namely, dermatitis and skin pigmentation diseases; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for use in ophthalmology; pharmaceutical preparations and substances for the treatment of polycystic ovary syndrome; pharmaceutical preparations and substances for the treatment of infertility; pharmaceutical preparations and substances for the prevention, treatment and alleviation of circulatory, neurologic, alimentary, auto-immune, pulmonary, musculoskeletal, lymphatic, gastrointestinal, bone sensory, viral, urinary, renal, infectious or metabolic diseases, illnesses, disorders or conditions; metformin; diltiazem; tramadol; carvedilol; bupropion; metoprolol; citalopram; zolpidem; fluoxetine; venlafaxine; lorazepam; and sumatriptan; rapidly dissolving drug delivery agents consisting of compounds that facilitate the delivery of a wide variety of pharmaceuticals

Trademark Events
Jan 22, 2014
Attorney Revoked And/Or Appointed
Jan 22, 2014
Teas Revoke/Appoint Attorney Received
Apr 25, 2011
Abandonment Notice Mailed - No Use Statement Filed
Apr 25, 2011
Abandonment - No Use Statement Filed
Apr 6, 2011
Assignment Of Ownership Not Updated Automatically
Mar 23, 2011
Assignment Of Ownership Not Updated Automatically
Oct 13, 2010
Assignment Of Ownership Not Updated Automatically
Oct 2, 2010
Notice Of Approval Of Extension Request E-Mailed
Oct 1, 2010
Extension 5 Granted
Sep 21, 2010
Extension 5 Filed
Sep 21, 2010
Teas Extension Received
Apr 13, 2010
Notice Of Approval Of Extension Request E-Mailed
Apr 12, 2010
Extension 4 Granted
Mar 17, 2010
Extension 4 Filed
Apr 12, 2010
Case Assigned To Intent To Use Paralegal
Mar 17, 2010
Teas Extension Received
Sep 18, 2009
Extension 3 Granted
Sep 15, 2009
Extension 3 Filed
Sep 15, 2009
Teas Extension Received
Jun 17, 2009
Assignment Of Ownership Not Updated Automatically
Apr 8, 2009
Extension 2 Granted
Mar 24, 2009
Extension 2 Filed
Apr 8, 2009
Case Assigned To Intent To Use Paralegal
Mar 24, 2009
Teas Extension Received
Jan 22, 2009
Applicant/Correspondence Changes (Non-Responsive) Entered
Jan 22, 2009
Teas Change Of Owner Address Received
Sep 19, 2008
Extension 1 Granted
Sep 19, 2008
Extension 1 Filed
Sep 19, 2008
Teas Extension Received
Mar 25, 2008
Noa Mailed - Sou Required From Applicant
Feb 5, 2008
Changes/Corrections After Pub Approval Entered
Feb 5, 2008
Assigned To Examiner
Jan 14, 2008
Fax Received
Jan 1, 2008
Published For Opposition
Dec 12, 2007
Notice Of Publication
Nov 23, 2007
Law Office Publication Review Completed
Nov 23, 2007
Assigned To Lie
Oct 18, 2007
Approved For Pub - Principal Register
Sep 29, 2007
Teas Change Of Correspondence Received
Sep 27, 2007
Teas Change Of Correspondence Received
Sep 27, 2007
Teas/Email Correspondence Entered
Sep 27, 2007
Correspondence Received In Law Office
Sep 27, 2007
Teas Request For Reconsideration Received
Mar 28, 2007
Final Refusal E-Mailed
Mar 28, 2007
Final Refusal Written
Mar 10, 2007
Teas/Email Correspondence Entered
Mar 9, 2007
Correspondence Received In Law Office
Mar 9, 2007
Teas Response To Office Action Received
Dec 13, 2006
Non-Final Action E-Mailed
Dec 13, 2006
Non-Final Action Written
Dec 13, 2006
Assigned To Examiner
Jul 21, 2006
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24